VAXCELL-BIO THERAPEUTICS revenue breakdown overview

The greatest contribution to the revenue figure was made by South Korea — last year it brought VAXCELL-BIO THERAPEUTICS 1.90 B KRW, and the year before that — 13.72 M KRW.